Life Science Leader - Home Page
Life Science Leader - thought leadership articles and discussions about the current life science industry
Pharmaceutical Scientists' Salaries in 2023
Jan 15, 2024 · Last October, the American Association of Pharmaceutical Scientists (AAPS) released its annual salary survey, which measures the earnings of individuals working in pharmaceutical sciences in the U.S., both in academia and industry.I expected the survey to reflect the harsh funding environment, layoffs, and inflation rate that impacted so many people working in the preceding 12 months.
A Glimpse Into David Lucchino Cofounder And CEO Of Frequency …
Sep 21, 2020 · By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL. David Lucchino, cofounder and CEO, Frequency Therapeutics. It was roughly 18 years ago when David Lucchino, CEO and cofounder of Frequency Therapeutics (and subject of an upcoming feature in Life Science Leader), first had the opportunity to meet famed MIT professor, Robert Langer, Sc.D.
Where Are They Now? Otsuka - Life Science Leader
May 30, 2024 · Then: In a Life Science Leader article headlined “Why Otsuka Diversified Into Digital Health,” published in 2016, Dr. William H. Carson, then president and CEO of Otsuka Pharmaceutical Development & Commercialization, Inc., explained the circumstances leading up to the formation of Otsuka Digital Health (ODH), a joint venture with IBM created to develop and market software for analyzing ...
Ahead Of The Curve On Radiopharmaceuticals - Life Science Leader
Jan 1, 2024 · By Ben Comer, Chief Editor, Life Science Leader. Tiffany Olson. Like the resurgent interest in antibody-drug conjugates (ADCs), following improvements in linker technology, payload capacity and precision targeting, radiopharmaceuticals are also having something of a moment.
The Benefits And Risks Of An LLC Business Model In Biotech
Oct 3, 2024 · <p>An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment and return. However, it won't work for every company, as Abbas Kazimi, chief business officer at Nimbus Therapeutics, explains.</p>
New Leadership At The Cancer Research Institute
Sep 27, 2024 · By Ben Comer, Chief Editor, Life Science Leader. Alicia Zhou, Ph.D. Dr. Alicia Zhou, Ph.D., the new CEO at the Cancer Research Institute (CRI), aims to bring her experience in academia and the West Coast health tech startup scene to bear on a 70-year-old nonprofit institution with deep roots in cancer immunotherapy.
Where Are They Now? Karuna Therapeutics - lifescienceleader.com
Jan 1, 2024 · By Ben Comer, Chief Editor, Life Science Leader. Steve Paul. Then: When Life Science Leader spoke with Karuna Therapeutics’ former CEO and current chief scientific officer Steve Paul in the summer of 2022, there was already significant buzz around KarXT, Karuna’s novel schizophrenia treatment. During one of our interviews, Paul noted that schizophrenia lowers a patient’s life expectancy ...
The Future of Anxiety Treatment Will Be Drastically Different
Sep 24, 2020 · As anxiety disorders become more common and stress from the diverse impacts of the COVID-19 pandemic threaten the mental/emotional well-being of Americans everywhere, it is clear that the current standard of care for anxiety disorders falls short in …
Where Are They Now? Carisma Therapeutics - lifescienceleader.com
Sep 22, 2024 · By Ben Comer, Chief Editor, Life Science Leader. Steven Kelly. Then: In a 2021 “Companies To Watch” article written by Wayne Koberstein, Carisma Therapeutics CEO Steven Kelly spoke about his three-pronged mandate to fund the (then) privately held company, build a team, and define a purpose. “Our purpose was to translate the discoveries made [by Michael Klichinsky and Saar Gill] at the ...